期刊文献+

Xenobiotic effects in cancer related pathways-high throughput screening and proof of concept in animal models

Xenobiotic effects in cancer related pathways-high throughput screening and proof of concept in animal models
下载PDF
导出
摘要 Xenobiotic drugs and chemicals directly interact with DNA,proteins,or other biomolecules in cells. These direct interactions with molecular targets may trigger a series of downstream effects on metabolic-biochemical and regulatory-signaling networks that can invoke cellular consequences leading to adaptive homeostatic or adverse pathological responses. Regulators for drug and chemicals safety have therefore since long required the testing of toxicity in animal models before drugs and pesticides can enter the market. The US National Research Council of the National Academy of Sciences,in its report,Toxicity Testing in the 21st Century: a Vision and a Strategy [1] ,proposed that toxicity testing should become less reliant on apical endpoints from whole animal tests and eventually rely instead on quantitative,doseresponse models based on information from in vitro assays and in vivo biomarkers,which can be used to screen large numbers of chemicals. The present paper reports about a combination of HTS in vitro assays that can be used to study the potential tumorigenic effect of xenobiotics ( drug targets,environmental chemicals) via a set of"sentinel"genes [2] that are functionally interrelated based on evidence weighted functional linkage network ( FLN ) log-likelihood scores ( Linghu et al [3] ) . Xenobiotic drugs and chemicals directly interact with DNA,proteins,or other biomolecules in cells. These direct interactions with molecular targets may trigger a series of downstream effects on metabolic-biochemical and regulatory-signaling networks that can invoke cellular consequences leading to adaptive homeostatic or adverse pathological responses. Regulators for drug and chemicals safety have therefore since long required the testing of toxicity in animal models before drugs and pesticides can enter the market. The US National Research Council of the National Academy of Sciences,in its report,Toxicity Testing in the 21st Century: a Vision and a Strategy [1] ,proposed that toxicity testing should become less reliant on apical endpoints from whole animal tests and eventually rely instead on quantitative,doseresponse models based on information from in vitro assays and in vivo biomarkers,which can be used to screen large numbers of chemicals. The present paper reports about a combination of HTS in vitro assays that can be used to study the potential tumorigenic effect of xenobiotics ( drug targets,environmental chemicals) via a set of"sentinel"genes [2] that are functionally interrelated based on evidence weighted functional linkage network ( FLN ) log-likelihood scores ( Linghu et al [3] ) .
出处 《中国比较医学杂志》 CAS 2013年第1期69-80,共12页 Chinese Journal of Comparative Medicine
关键词 基础医学 呼吸生理 呼吸运动 人体生理学 Xenobiotic drugs Xenobiotic chemicals In vitro assays High throughput screening Cancer TP53 FOS JUN Steroidal and non-steroidal nuclear receptors MAP kinases
  • 相关文献

参考文献31

  • 1Krewski D.. "Toxicity Testing in the 21st Century: A Vision and a Strategy", Committee on Toxicity Testing and Assessment of Environmental Agents. National Academies Press, Washington, DC, USA. (2007).
  • 2R.S. Judson, H. M. Mortensen, I. Shah, T. Knudsen, F. Eiloumi, " Using Pathway Modules as Targets for Assay Development in Xenobiotic Screening", Mol. Biosyst. , 8 [ 2 ], 531 -542 (2012).
  • 3B. Linghn, E. Snitkin, Z. Hu, Y. Xia, C. DeLisi, ,,Genome- wide prioritization of disease genes and identification of disease- disease associations from an integrated human functional linkage network", Genome Biology, 2009, 10(9), R91.
  • 4Desmond, Adrian ; Moore, James ( 1991 ). "Darwin". London: Michael Joseph, Penguin Group. ISBN 0-7181-3430-3.
  • 5Williams, G. C. [ 1957 ]. "Pleiotropy, Natural Selection, and the Evolution of Senescence". Evolution 11 ( 4 ) : 398 - 411. doi:10. 2307/2406060. JSTOR 2406060.
  • 6Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A. , "Concordance of the toxicity of pharmaceuticals in humans and in animals. " Regul Toxicol Pharmacol. 2000 Aug;32 ( 1 ) :56 - 67. Review.
  • 7N. Shanks, C. R. Greek "Animal Models in the Light of Evolution" Boca Raton: BrownWalker Press; 2009. 443 pages, ISBN-10: 1599425025; ISBN-13 : 9781599425023.
  • 8Shanks N., Greek C. R., Greek J. " Are animal models predictive for humans?" Philosophy, Ethics and Humanities in Medicine 2009, 4:2 doi : 10. 1186/1747-5341-4-2.
  • 9FDA Issues Advice to Make Earliest Stages Of Clinical Drug Development More Efficient [ http://www, fda. gov/bbs/topics/ news/2006/NEW01296, html].
  • 10Heywood R, " Clinical Toxicity-Could it have been predicted? Post-marketing experience. " Animal Toxicity Studies: Their Relevance for Man 1990:57 - 67.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部